A person receiving IV insulin for hyperglycemia would be monitored for
The correct answer and explanation is:
A person receiving IV insulin for hyperglycemia would be monitored for hypoglycemia.
Insulin therapy, particularly when administered intravenously for hyperglycemia, requires careful monitoring because insulin works rapidly to lower blood glucose levels. While its primary goal is to reduce elevated glucose, it can cause hypoglycemia if the dosage is too high, the patient’s insulin sensitivity is increased, or there is insufficient food intake. The body’s glucose levels drop too low, leading to symptoms like dizziness, confusion, sweating, shaking, and, in severe cases, loss of consciousness or seizures.
The patient’s blood glucose levels should be regularly checked to ensure they do not drop below a safe threshold. Typically, a blood glucose level below 70 mg/dL is considered hypoglycemia, though some patients may experience symptoms at slightly higher levels. Additionally, insulin can cause a shift in electrolyte balance, particularly potassium levels. Insulin promotes the movement of potassium into cells, which can lead to hypokalemia, another concern that must be monitored.
Frequent monitoring of the patient’s blood glucose, as well as electrolyte levels like potassium, sodium, and bicarbonate, is essential to ensure that the insulin is effective but not causing adverse effects. If blood glucose drops too rapidly or to a dangerously low level, the IV insulin infusion rate may need to be reduced or halted, and interventions like the administration of glucose may be necessary to correct hypoglycemia.
In summary, while IV insulin is a vital treatment for hyperglycemia, it must be carefully monitored to avoid complications such as hypoglycemia and electrolyte imbalances, ensuring the safety and well-being of the patient.